全文获取类型
收费全文 | 11177篇 |
免费 | 626篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 152篇 |
儿科学 | 665篇 |
妇产科学 | 177篇 |
基础医学 | 1139篇 |
口腔科学 | 205篇 |
临床医学 | 721篇 |
内科学 | 2770篇 |
皮肤病学 | 233篇 |
神经病学 | 1070篇 |
特种医学 | 455篇 |
外科学 | 1557篇 |
综合类 | 243篇 |
一般理论 | 5篇 |
预防医学 | 516篇 |
眼科学 | 332篇 |
药学 | 692篇 |
中国医学 | 29篇 |
肿瘤学 | 886篇 |
出版年
2023年 | 76篇 |
2022年 | 125篇 |
2021年 | 317篇 |
2020年 | 201篇 |
2019年 | 249篇 |
2018年 | 307篇 |
2017年 | 219篇 |
2016年 | 297篇 |
2015年 | 284篇 |
2014年 | 464篇 |
2013年 | 540篇 |
2012年 | 874篇 |
2011年 | 882篇 |
2010年 | 503篇 |
2009年 | 425篇 |
2008年 | 687篇 |
2007年 | 722篇 |
2006年 | 682篇 |
2005年 | 645篇 |
2004年 | 613篇 |
2003年 | 505篇 |
2002年 | 450篇 |
2001年 | 121篇 |
2000年 | 154篇 |
1999年 | 139篇 |
1998年 | 93篇 |
1997年 | 62篇 |
1996年 | 51篇 |
1995年 | 57篇 |
1994年 | 47篇 |
1993年 | 31篇 |
1992年 | 74篇 |
1991年 | 58篇 |
1990年 | 59篇 |
1989年 | 92篇 |
1988年 | 67篇 |
1987年 | 72篇 |
1986年 | 62篇 |
1985年 | 60篇 |
1984年 | 65篇 |
1983年 | 49篇 |
1979年 | 28篇 |
1978年 | 20篇 |
1977年 | 22篇 |
1975年 | 23篇 |
1974年 | 24篇 |
1972年 | 25篇 |
1970年 | 22篇 |
1969年 | 26篇 |
1967年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 390 毫秒
951.
Eleven Cases of "Bombay" Phenotype in Six Families: Suppression of ABO Antigen Demonstrated in Two Families 总被引:1,自引:0,他引:1
Eleven cases of "Bombay" phenotype in six different Indian families are reported. Two of the families show evidence for the suppression of the ABO antigens. In one family B antigen was involved in two sibs with "Bombay" phenotype and in the other suppression was evident but the true ABO groups could not be ascertained. Most cases are identified due to crossmatching difficulty but a few cases are reported in this article which were detected through the cells. The common occurence of these cases from Bombay is pointed out and the importance of using anti-H as one of the reagents in doing ABO grouping in India is stressed. 相似文献
952.
953.
Insulin resistance in polycystic ovarian disease 总被引:2,自引:0,他引:2
Bhatia V 《Southern medical journal》2005,98(9):903-10; quiz 911-2, 923
The classic polycystic ovarian syndrome (PCOS) was originally described by Stein and Leventhal as the association of amenorrhea with polycystic ovaries and, variably, hirsutism and/or obesity. It is estimated that 5 to 10% of women of reproductive age have PCOS. Although insulin resistance is not part of the diagnostic criteria for PCOS, its importance in the pathogenesis of PCOS can not be denied. PCOS is associated with insulin resistance, independent of total or fat-free body mass. Postreceptor defects in the action of insulin have been described in PCOS that are similar to those found in obesity and type 2 diabetes. Treatment with insulin sensitizers, metformin, and thiazolidinediones (TZDs) improve both metabolic and hormonal patterns and also improve ovulation in PCOS. Recent studies have shown that women who have PCOS have higher circulating levels of inflammatory mediators such as C-reactive protein, tumor necrosis factor, tissue plasminogen activator, and plasminogen activator inhibitor-1 (PAI-1). It is possible that the beneficial effect of insulin sensitizers in PCOS may be partly due to a decrease in inflammation. 相似文献
954.
Pablo Menendez Lisheng Wang Kristin Chadwick Li Li Mickie Bhatia 《Molecular therapy》2004,10(6):1109-1120
Human embryonic stem cells (hESCs) provide a unique opportunity to study molecular mechanisms that regulate specification of the hematopoietic lineage in the human. Exploitation of this model using transgenic strategies depends on the ability to target cells of the hematopoietic lineage effectively and establish stable transgene expression. Here, a recently defined subpopulation of endothelial-like precursors derived from hESCs that is exclusively responsible for hematopoietic cell fate (CD45(neg)PFV) is shown to express GALVR-1 receptor and be efficiently transduced with GALV-pseudotyped retrovirus. Retroviral transduction, measured by enhanced green fluorescent protein, of hESC-derived CD45(+) cells differentiated from isolated CD45(neg)PFV precursors was 26.5 +/- 13% with 5.6 +/- 4% of these cells coexpressing CD34. An average of 17.5% of clonogenic hematopoietic progenitors derived from CD45(neg)PFV precursors expressed the retroviral transgene. Addition of serum to cultures after retroviral exposure supported transgene expression in resulting hematopoietic cells derived from hemogenic CD45(neg)PFV precursors. Our study represents the first report to demonstrate that retroviral transduction systems, similar to those used currently in clinical gene therapy protocols, are capable of efficient transduction of hematopoietic progenitors derived from hESCs. 相似文献
955.
Karen M. Kim MD Francis Shannon MD Gaetano Paone MD MHSA Shelly Lall MD Sanjay Batra MD Theodore Boeve MD Alphonse DeLucia MD Himanshu J. Patel MD Patricia F. Theurer MSN Chang He MS Melissa J. Clark MSN Ibrahim Sultan MD George Michael Deeb MD Richard L. Prager MD 《Journal of cardiac surgery》2018,33(8):424-430
Background
Transcatheter aortic valve replacement (TAVR) is an alternative to surgical aortic valve replacement (SAVR) for the treatment of aortic stenosis in patients at intermediate, high, and extreme risk for mortality from SAVR. We examined recent trends in aortic valve replacement (AVR) in Michigan.Methods
The Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative (MSTCVS‐QC) database was used to determine the number of SAVR and TAVR cases performed from January 2012 through June 2017. Patients were divided into low, intermediate, high, and extreme risk groups based on STS predicted risk of mortality (PROM). TAVR patients in the MSTCVS‐QC database were also matched with those in the Transcatheter Valve Therapy Registry to determine their Heart Team‐designated risk category.Results
During the study period 9517 SAVR and 4470 TAVR cases were performed. Total annual AVR volume increased by 40.0% (from 2086 to 2920), with a 13.3% decrease in number of SAVR cases (from 1892 to 1640) and a 560% increase in number of TAVR cases (from 194 to 1280). Greater than 90% of SAVR patients had PROM ≤8%. While >70% of TAVR patients had PROM ≤ 8%, they were mostly designated as high or extreme risk by a Heart Team.Conclusions
During the study period, SAVR volume gradually declined and TAVR volume dramatically increased. This was mostly due to a new group of patients with lower STS PROM who were designated as higher risk by a Heart Team due to characteristics not completely captured by the STS PROM score. 相似文献956.
957.
Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers
BACKGROUND: Modafinil has been reported to produce a concentration-related induction of CYP3A4/5 activity in vitro in primary cultures of human hepatocytes. OBJECTIVE: Our objective was to determine whether the pharmacokinetics of steady-state ethinyl estradiol (INN, ethinylestradiol) and single-dose triazolam were altered after 4 weeks of modafinil treatment in volunteers. METHODS: This was a placebo-controlled, single-blind, single-period study in 41 female subjects who were receiving long-term treatment with an oral contraceptive that contained ethinyl estradiol (0.035 mg) and norgestimate (0.180-0.250 mg). Pharmacokinetic profiles for ethinyl estradiol and for a single oral dose of triazolam (0.125 mg) were obtained the day before initiation of treatment with modafinil (200 mg for 7 days, followed by 400 mg for 21 days) or placebo (28 days). A second dose of triazolam was administered with the final dose of modafinil, and pharmacokinetic profiling was repeated. RESULTS: The modafinil treatment group had a marked decrease in maximum observed plasma concentrations and areas under the plasma concentration-time curve for triazolam relative to placebo, with a much smaller decrease in these parameters for ethinyl estradiol. The half-life of triazolam was also decreased, but the half-life of ethinyl estradiol did not appear to be affected by treatment with modafinil. CONCLUSION: Modafinil induced CYP3A4/5 activity in humans in vivo, suggesting that there is potential for metabolic drug-drug interactions between modafinil and substrates of CYP3A4/5. However, the induction appeared to be more gastrointestinal than hepatic in nature. Therefore significant metabolic drug-drug interactions are most likely to occur with compounds (such as triazolam) that undergo significant gastrointestinal CYP3A4/5-mediated first-pass metabolism. 相似文献
958.
959.
Hendrix JA Wamhoff BR McDonald OG Sinha S Yoshida T Owens GK 《The Journal of clinical investigation》2005,115(2):418-427
CC(A/T)6GG-dependent (CArG-dependent) and serum response factor-dependent (SRF-dependent) mechanisms are required for gene expression in smooth muscle cells (SMCs). However, an unusual feature of many SMC-selective promoter CArG elements is that they contain a conserved single G or C substitution in their central A/T-rich region, which reduces binding affinity for ubiquitously expressed SRF. We hypothesized that this CArG degeneracy contributes to cell-specific expression of smooth muscle alpha-actin in vivo, since substitution of c-fos consensus CArGs for the degenerate CArGs resulted in relaxed specificity in cultured cells. Surprisingly, our present results show that these substitutions have no effect on smooth muscle-specific transgene expression during normal development and maturation in transgenic mice. However, these substitutions significantly attenuated injury-induced downregulation of the mutant transgene under conditions where SRF expression was increased but expression of myocardin, a smooth muscle-selective SRF coactivator, was decreased. Finally, chromatin immunoprecipitation analyses, together with cell culture studies, suggested that myocardin selectively enhanced SRF binding to degenerate versus consensus CArG elements. Our results indicate that reductions in myocardin expression and the degeneracy of CArG elements within smooth muscle promoters play a key role in phenotypic switching of smooth muscle cells in vivo, as well as in mediating responses of CArG-dependent smooth muscle genes and growth regulatory genes under conditions in which these 2 classes of genes are differentially expressed. 相似文献
960.
A cholecystokinin-releasing factor mediates ethanol-induced stimulation of rat pancreatic secretion.
下载免费PDF全文
![点击此处可从《The Journal of clinical investigation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A K Saluja L Lu Y Yamaguchi B Hofbauer M Rünzi R Dawra M Bhatia M L Steer 《The Journal of clinical investigation》1997,99(3):506-512
The mechanisms by which short-term ethanol administration alters pancreatic exocrine function are unknown. We have evaluated the effects of ethanol administration on pancreatic secretion of digestive enzymes. In our studies, anesthetized as well as conscious rats were given ethanol at a rate sufficient to cause the blood ethanol concentration to reach levels associated with clinical intoxication. Ethanol was administered over a 2-h period during which blood ethanol levels remained stably elevated. We report that intravenous administration of ethanol results in a transient increase in pancreatic amylase output and plasma cholecystokinin (CCK) levels. The ethanol-induced increase in amylase output can be completely inhibited by the CCK-A receptor antagonist L-364,718 and partially inhibited by the muscarinic cholinergic antagonist atropine. The ethanol-induced rise in amylase output can be completely prevented by instillation of trypsin into the duodenum or by lavage of the duodenum with saline during ethanol administration. Furthermore, the intraduodenal activity of a CCK-releasing factor is increased by infusion of ethanol. These studies indicate that administration of ethanol causes rat pancreatic exocrine secretion to increase. This phenomenon is mediated by a trypsin-sensitive CCK-releasing factor which is present within the duodenal lumen. These observations lead us to speculate that repeated CCK-mediated ethanol-induced stimulation of pancreatic digestive enzyme secretion may play a role in the events which link ethanol abuse to the development of pancreatic injury. 相似文献